Healthy year equivalents versus quality-adjusted life years: The debate continues

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 5, Issue 3, 2005, Pages 245-254

  Towers, Isabel ^a   Spencer, Anne ^b   Brazier, John ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Expected utility theory; Health profiles; Healthy year equivalents; Preferences; Quality adjusted life years

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ARTICLE; CHOLELITHIASIS; COGNITION; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; HEALTH CARE DELIVERY; HEALTH STATUS; HEALTH SURVEY; HUMAN; LAPAROSCOPIC SURGERY; LITHOTRIPSY; MEDICAL RESEARCH; MORTALITY; POSTOPERATIVE COMPLICATION; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RISK ASSESSMENT; SCLEROTHERAPY; STANDARDIZATION; STATISTICAL ANALYSIS; VARICOSIS; VASCULAR SURGERY;

EID: 21244456488     PISSN: 14737167     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737167.5.3.245     Document Type: Article

References (63)

1. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Healthcare Programmes. Oxford Medical Publications, Oxford, UK (1997).
2. National Institute for Clinical Excellence. NICE Guide to the Methods of Technology Appraisal. NICE, 2004, London, UK (2004).
3. Mehrez A, Gafni A. Quality-adjusted life years, utility theory, and healthy-years equivalents. 10(2), 148-149 Med. Decis. Making 9, 142-149 (1989).
4. Mehrez A, Gafni A. Evaluating health related quality of life: an indifference curve interpretation for the time trade-off technique. Soc. Sci. Med. 31, 1281-1283 (1990).
5. Mehrez A, Gafni A. The healthy-years equivalents: how to measure them using the standard gamble approach. Med. Decis. Making 11, 140-146 (1991).
6. Buckingham K. A note on hye (healthy years equivalent). J. Health Econ. 12, 301-309 (1993).
7. Buckingham K. Economics, health and health economics - HYEs versus QALYs - a response. J. Health Econ. 14, 397-398 (1995).
8. Gafni A, Birch S, Mehrez A. Economics, health and Health econ. - HYEs versus QALYs. J. Health Econ. 12, 325-339 (1993).
9. Culyer AJ, Wagstaff A. QALYs versus HYEs. J. Health Econ. 12, 311-323 (1993).
10. Loomes, G. The myth of the HYE. J. Health Econ. 14, 1-7 (1995).
11. Pliskin JS, Shepard DS, Weinstein MC. Utility functions for life years and health status. Operations Res. 28, 206-224 (1980).
12. Miyamoto JM, Eraker SA. Parameter estimates for a QALY utility model. Med. Decis. Making 5, 191-213 (1985).
13. Bleichrodt H, Wakker P, Johannesson M. Characterizing QALYs by risk neutrality. J. Risk Uncertainty 15, 107-114 (1997).
14. Miyamoto JM, Eraker SA. A multiplicative model of the utility of survival duration and health quality. J. Exp. Psychol. Gen. 117, 3-20 (1988).
15. Keeney RL, Raiffa H. Decisions With Multiple Objectives: Preferences and Value Trade-Offs, Second Edition. Cambridge University Press, Cambridge, UK (1976).
16. Miyamoto JM, Wakker PP, Bleichrodt H, Peters HJM. The zero-condition: a simplifying assumption in QALY measurement and multiattribute utility. Management Science 44, 839-849 (1998).
17. Loomes G, McKenzie L. The use of QALYs in healthcare decision making. Soc. Sci. Med. 28, 299-308 (1989).
18. Llewellyn-Thomas HA, Arshinoff R, Bell M, Williams JI, Naylor CD. Healthy-year equivalents in major joint replacement: can patients provide meaningful responses? Int. J. Technol. Assess. Health Care 18(3), 467-484 (2002).
19. Johannesson M. Quality-adjusted life-years versus healthy-years equivalents - a comment. J. Health Econ. 14, 9-16 (1995).
20. Morrison G. HYE and TTO: what is the difference? Health Econ. 16, 563-578 (1997).
21. Johannesson M. The ranking properties of healthy-years equivalents and quality-adjusted life-years under certainty and uncertainty. Int. J. Technol. Assess. Health Care 11(1), 40-48 (1995).
22. Gafni A, Birch S. QALYs and HYEs: spotting the differences. J. Health Econ. 16, 601-608 (1997).
23. Ried W. QALYs versus HYEs - what's right and what's wrong. A review of the controversy. J. Health Econ. 17, 607-625 (1998).
24. Cook J, Richardson J, Street A. A cost-utility analysis of treatment options for gallstone disease - methodological issues and results. Health Econ. 3, 157-168 (1994).
25. Sculpher M. Comparing QALYs and HYEs: The Case of Hysterectomy Versus Trancervical Endometrial Rejection. Paper presented to the Health Economists' Study Group, York, UK (1996).
26. Bleichrodt H. QALYs and HYEs: under what conditions are they equivalent? J. Health Econ. 14, 17-37 (1995).
27. Bleichrodt H, Gafni A. Time preference, the discounted utility model and health. J. Health Econ. 15, 49-66 (1996).
28. Sutherland HJ, Llewellyn-Thomas H, Boyd NF, Till JE. Attitude toward quality of survival: the concept of maximal endurable time Med. Decis. Making 2, 299-309 (1982).
29. Guerrero AM, Herrero C. A semi-separable utility function for health profiles J. Health Econ. 24, 35-54 (2005).
30. Miyamoto JM. Quality-adjusted life years (QALY) utility models under expected utility and rank-dependent utility assumptions. J. Math. Psychol. 43, 201-237 (1999).
31. Bleichrodt H, Miyamoto J. A characterization of quality-adjusted life-years under cumulative prospect theory. Mathemati. Oper. Res. 28(1), 181-93 (2003).
32. Stalmeier PFM, Chapman GB, de Boor AGEM, van Lanschot JJB. A fallacy of the multiplicative QALY model for low-quality weights in students and patients judging hypothetical health states. Int. J. Technol. Assess. Health Care 17, 488-496 (2001).
33. Dolan P, Gudex C. Time preferences, duration and health state valuations. Health Econ. 4, 289-299 (1995).
34. Richardson J, Hall J, Salkfeld G. The measurement of utility in multiphase health states. Int. J. Technol. Assess. Health Care 12, 151-162 (1996).
35. Mackeigan LD, O'Brien BJ, Oh PI. Holistic versus composite preferences for lifetime treatment sequences for Type 2 diabetes. Med. Decis. Making 19, 113-121 (1999).
36. Ariely D, Zauberman G. On the making of an experience: the effects of breaking and combining experiences on their overall evaluation. J. Behav. Decis. Making 13, 219-232 (2000).
37. Ariely D, Zauberman G. Differential partitioning of extended experiences. Organizational Behavior and Human Decision Processes. 91(2), 128-139 (2003).
38. Ariely D. Combining experiences over time: the effects of duration, intensity changes and on-line measurements on retrospective pain evaluations. J. Behav. Decis. Making 11, 19-45 (1998).
39. Loewenstein G, Prelec D. Preferences for sequences of outcomes. Psychol. Rev. 100, 91-108 (1993).
40. Gafni A. Time in health: can we measure individuals' pure time preferences? Med. Decis. Making 15, 31-37 (1995).
41. Lipscomb J. Time preference for health in cost-effectiveness analysis. Med. Care 27, S233-S253 (1989).
42. Kuppermann M, Shiboski S, Feeny D, Elkin EP, Washington AE. Can preference scores for discrete states be used to derive preference scores for an entire path of events? An application to prenatal diagnosis. Med. Decis. Making 17, 42-55 (1997).
43. Holmes AM. Measurement of short-term health effects in economic evaluations. Pharmacoeconomics 13, 171-174 (1998).
44. Krabbe PFM, Bonsel GJ. Sequence effects, health profiles, and the QALY model. Med. Decis. Making 18, 178-186 (1998).
45. Spencer A. A test of the QALY model when health varies over time. Soc. Sci. Med. 57, 1697-1706 (2003).
46. Brazier J, Dolan P, Karampela K, Towers I. Does the Whole Equal the Sum of the Parts? Patient-Assigned Utility Scores for IBS-Related Health States and Profile. Health Economics and Decision Science Discussion Paper, School of Health and Related Research, The University of Sheffield, UK (2004).
47. Towers IMF. The Valuation of Health Outcomes Data from Clinical Trials for Use in Economic Evaluations. PhD thesis, School of Health and Related Research, University of Sheffield, UK (2003).
48. Taylor IMF. Testing Attitudes to Short-Term Risk for Abdominal Aortic Aneurysm Scenarios. Paper presented to the Health Economics Study Group, Uxbridge, UK (2002).
49. McNeil BJ, Weichselbaum R, Pauker SG. Fallacy of the five-year survival in lung cancer. N. Engl. J. Med. 299, 1397-1401 (1978).
50. McNeil BJ, Weichselbaum R, Pauker SG. Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. N. Engl. J. Med. 305, 982-987 (1981).
51. Treadwell JR. Tests of preferential independence in the QALY model. Med. Decis. Making 18, 418-428 (1998).
52. Bleichrodt H, Quiggin. Characterising QALYs under a general rank-dependent. J. Risk Uncertainty 15, 151-165 (1997).
53. Gigerenzer G, Todd P, AR Group. Evolution and Cognition. In: Simple Heuristics That Make Us Smart. Stich S (Ed.), Oxford University Press, NY, USA (1997).
54. Diamond PA, Hausman JA, Leonard GK, Denning MA. Does contingent Valuation measure preferences? Experimental evidence. In: Contingent Valuation: A Critical Assessment. Hausman JA (Ed.), Elsevier, Amsterdam, The Netherlands (1993).
55. Kartman B, Stalhammar NO, Johannesson M. Valuation of health changes with the contingent valuation method: a test of scope and question order effects. Health Econ. 5, 531-541 (1996).
56. Healey A, Chrisholm D. Willingness to pay as a measure of the benefits of mental healthcare. J. Ment. Health Policy Econ. 2, 55-58 (1999).
57. Carlsson F, Johansson-Stenman O. Willingness to pay for improved air quality in Sweden. Appl. Economics 32(6), 661-669 (2000).
58. Redelmeier DA, Heller DN. Time preference in medical decision-making and cost-effectiveness. Med. Decis. Making 13, 212-217 (1993).
59. Polak BCP, Wessling H, Shut D et al. Blood dyscrasias attributed to chloramphenicol: a review of 576 published and unpublished cases. Acta Med. Scand. 192, 409-414 (1972).
60. Owens DK, Nease RF. Occupational exposure to human immunodeficiency virus and hepatitis B virus: a comparative analysis of risk. Am. J. Med. 92, 503-512 (1992).
61. Kahneman D, Snell J. Predicting utility. In: Insights in Decision Making. Hogarth RAM (Ed.), Universiy of Chicago Press, IN, USA (1990).
62. Boyd NF, Sutherland HJ, Heasman KZ, Tritchler DL, Cummings BJ. Whose utilities for decision analysis? Med. Decis. Making 1, 58-67 (1990).
63. Fryback DG. Whose quality of life? Or whose decision? Qual. Life Res. 12, 609-610 (2003).